DOSE-DEPENDENT AND TIME-DEPENDENT PHARMACOKINETICS IN THE DOG AFTER INTRAVENOUS ADMINISTRATION OF DEXTRORPHAN

被引:0
作者
CLEVELAND, PA [1 ]
TELLER, S [1 ]
KACHEVSKY, V [1 ]
PINILI, E [1 ]
EVANS, R [1 ]
MODI, MW [1 ]
机构
[1] HOFFMANN LA ROCHE INC,DEPT DRUG METAB,NUTLEY,NJ 07110
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition of dextrorphan after single ascending iv doses and multiple iv dosing regimens was studied in Marshall beagle dogs. A dose-dependent decrease in plasma clearance was observed after the administration of single iv doses of 0.88 mg/kg, 2.64 mg/kg, and 8.8 mg/kg of dextrorphan (i.e. mean plasma clearance values +/- SD were 100 +/- 25 vs. 68 +/- 28 vs. 48 +/- 20 ml/min.kg, respectively; p < 0.001). Upon multiple dosing, the plasma clearance of dextrorphan increased in a time-dependent fashion for the two highest doses, approaching values observed for the 0.88 mg/kg/day iv dosing regimen. Female dogs exhibited a greater increase in plasma clearance with time. For all dogs, however, dextrorphan plasma clearance approached or exceeded hepatic plasma flow rate, suggesting the possibility of extrahepatic metabolism or elimination. Modest dose- and time-dependent changes in the steady-state volume of distribution of dextrorphan also were observed. The AUC of the conjugated metabolites of dextrorphan decreased in a time-dependent manner for the 8.8 mg/kg/day dosing regimen. The nonlinear kinetics of dextrorphan after iv administration appeared to occur only after potentially toxic dosing regimens of dextrorphan hydrochloride. We postulate mechanisms to explain the dose- and time-dependent kinetics of dextrorphan observed in the beagle dog.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 27 条
[2]  
CHOI DW, 1987, J PHARMACOL EXP THER, V242, P713
[3]  
DAHSTROM BE, 1978, J PHARMACOKINET BIOP, V6, P505
[4]  
DIXON R, 1978, RES COMMUN CHEM PATH, V22, P243
[5]   DEXTROMETHORPHAN AND CAFFEINE AS PROBES FOR SIMULTANEOUS DETERMINATION OF DEBRISOQUIN-OXIDATION AND N-ACETYLATION PHENOTYPES IN CHILDREN [J].
EVANS, WE ;
RELLING, MV ;
PETROS, WP ;
MEYER, WH ;
MIRRO, J ;
CROM, WR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) :568-573
[6]   PHARMACOKINETICS OF MORPHINE AND ITS SURROGATES .3. MORPHINE AND MORPHINE 3-MONOGLUCURONIDE PHARMACOKINETICS IN THE DOG AS A FUNCTION OF DOSE [J].
GARRETT, ER ;
JACKSON, AJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (06) :753-771
[7]   DEXTROMETHORPHAN REDUCES NEOCORTICAL ISCHEMIC NEURONAL DAMAGE INVIVO [J].
GEORGE, CP ;
GOLDBERG, MP ;
CHOI, DW ;
STEINBERG, GK .
BRAIN RESEARCH, 1988, 440 (02) :375-379
[8]  
GIBALDI M, 1982, PHARMACOKINETICS, V15, P409
[9]   HEPATIC VASCULAR BED [J].
GREENWAY, CV ;
STARK, RD .
PHYSIOLOGICAL REVIEWS, 1971, 51 (01) :23-+
[10]  
JACQZ E, 1986, DRUG METAB DISPOS, V14, P627